Clinicopathological features of breast cancer with different molecular subtypes in chinese women

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 1, 2013, Pages 117-121

  Cheng, Hong Tao ^a,b   Huang, Tao ^a   Wang, Wei ^b   Yue, Jun Qiu ^b   Shen, Na ^a   Guo, Hui ^a   Li, Da Peng ^a   Zhao, Qun Zi ^a   Yi, Peng Fei ^a   Wang, Rui ^a   Wang, Long Qiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI CANCER HOSPITAL   (China)

Author keywords

breast cancer; clinicopathological features; molecular subtypes

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ARTICLE; BREAST TUMOR; CHINA; CLASSIFICATION; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; MOLECULAR DIAGNOSIS; PATHOLOGY; PREVALENCE; STATISTICS;

BREAST NEOPLASMS; CHINA; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PREVALENCE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 84873628179     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1082-2     Document Type: Article

References (22)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin, 2000,50(1):7-33
2. Tavassoli FA, Schnitt SJ. Pathology of the breast. New York: Elsevier, 1992:27-36
3. Wiencke JK. Opinion: Impact of race/ethnicity on molecular pathways in human cancer. Nat Rev Cancer, 2004,4(1):79-84
4. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA, 2003,100(14):8418-8423
5. Brenton JD, Carey LA, Ahmed AA, et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol, 2005,23(29): 7350-7360
6. Nguyen PL, Taghian AG, Katz MS, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast conserving therapy. J Clin Oncol, 2008,26(14):2373-2378
7. Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res, 2005,11(16): 5678-5685
8. Voduc KD, Cheang MCU, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 2010,28(10):1684-1691
9. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature, 2000,406(6797):747-752
10. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 2001,98(19):10 869-10 874
11. Wiecmann L, Sampson M, Stempel M, et al. Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol, 2009,16(10):2705-2710
12. Blackman DJ, Masi CM. Racial and ethnic disparities in breast cancer mortality: Are we doing enough to address the root causes? J Clin Oncol, 2006,24(14):2170-2178
13. Crabb SJ, Cheang MC, Leung S, et al. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer. Clin Breast Cancer, 2008,8(3):249-256
14. Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109(1):25-32
15. Haffty BG, Yang Q, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 2006,24(36):5652-5657
16. Kim MJ, Ro JY, Ahn SH, et al. Clinicopathologic significance of the basal-like subtype of breast cancer: A comparison with hormone receptor and Her2/neu-over-expressing phenotypes. Hum Pathol, 2006,37(9):1217-1226
17. Kurebayashi J, Moriya T, Ishida T, et al. The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast, 2007,16(suppl 2):s72-77
18. Ihemelandu CU, Leffall LD Jr, Dewitty RL, et al. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res, 2007,143(1): 109-118
19. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst, 2005,97(6): 439-448
20. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 2004,10(16):5367-5374
21. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the carolina breast cancer study. JAMA, 2006,295(21):2492-2502
22. Rakha EA, El-Rehim DA, Paish C, et al. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Eur J Cancer, 2006,42(18):3149-3156